Stage IIA Prostate Cancer Completed Phase 2 Trials for Leuprolide (DB00007)

IndicationStatusPhase
DBCOND0028878 (Stage IIA Prostate Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01023061Abiraterone Acetate, Prednisone, and Leuprolide Acetate or Goserelin Before and During Radiation Therapy in Treating Patients With Localized or Locally Advanced Prostate CancerTreatment
NCT00589472Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate CancerTreatment